This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Kyungjin Peter Kim, Ph.D.
President, CEO at ST Pharm Co Ltd.


 Expert in new drug discovery and development with over 30 years of academy and industrial
experience in metabolic disease, virology, inflammation and oncology therapeutic area
 Extensive knowledge and experience with a proven track record of target validation, lead
optimisation library design, solid-phase synthesis and novel technology innovation (solidsupport
reagents, microwave, SFC, CFT, SMB, and etc.)
 Skilled managing in new chemical entity CMO/CDMO manufacturing and non-clinical CRO

Agenda Sessions

  • Expediting mRNA Vaccine Development: How to Develop mRNA Platform Technology Using Know-how from the Oligonucleotide CDMO Business


Speakers at this event